Evidence mapPaperPMID 33101585Full record

ArticleOxidative medicine and cellular longevity2020

Phillyrin Mitigates Apoptosis and Oxidative Stress in Hydrogen Peroxide-Treated RPE Cells through Activation of the Nrf2 Signaling Pathway.

Yuanyuan Du, Longtai You, Boran Ni, Na Sai, Wenping Wang, Mingyi Sun, Rui Xu, Yu Yao, Zhiqin Zhang, Changhai Qu and 2 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Polysaccharides FromFrontiers in veterinary science · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yuanyuan DuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.ORCID https://orcid.org/0000-0003-4137-4044
Longtai YouSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.ORCID https://orcid.org/0000-0002-5600-353X
Boran NiDongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100029, China.ORCID https://orcid.org/0000-0002-0353-9947
Na SaiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.ORCID https://orcid.org/0000-0002-8957-9949
Wenping WangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.ORCID https://orcid.org/0000-0002-9488-9474
Mingyi SunSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.ORCID https://orcid.org/0000-0002-6759-5446
Rui XuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.ORCID https://orcid.org/0000-0002-6631-9386
Yu YaoSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.ORCID https://orcid.org/0000-0003-2246-0721
Zhiqin ZhangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.ORCID https://orcid.org/0000-0003-2127-6404
Changhai QuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.ORCID https://orcid.org/0000-0001-6617-1476
Xingbin YinSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.ORCID https://orcid.org/0000-0003-3077-1626
Jian NiBeijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.ORCID https://orcid.org/0000-0003-1974-044X
Beijing University of Chinese Medicine · CNDongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress-induced dysfunction or apoptosis in retinal pigment epithelial (RPE) cells is an important cause of dry age-related macular degeneration (AMD). Although phillyrin has been shown to exert significant antioxidant effects, the underlying mechanism of action remains unclear. The purpose of this study was to investigate the protective effect of phillyrin on hydrogen peroxide- (H

Indexed as

ApoptosisCell LineG1 Phase Cell Cycle CheckpointsGlucosidesHeme Oxygenase-1HumansHydrogen PeroxideKelch-Like ECH-Associated Protein 1MalondialdehydeMembrane Potential, MitochondrialMitochondriaNAD(P)H Dehydrogenase (Quinone)NF-E2-Related Factor 2Oxidative StressReactive Oxygen SpeciesRetinal Pigment EpitheliumGlucosidesHeme Oxygenase-1Hydrogen PeroxideKelch-Like ECH-Associated Protein 1MalondialdehydeNAD(P)H Dehydrogenase (Quinone)NF-E2-Related Factor 2NQO1 protein, humanphillyrinReactive Oxygen Species

Identifiers

PMID33101585
PMCPMC7576358
OpenAlexW3092609200

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.